申请人:Hoechst Aktiengesellschaft
公开号:US05547970A1
公开(公告)日:1996-08-20
N-(4-Trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide is an effective compound for preventing and treating disorders in which tumor necrosis factor alpha is involved. It is used as a pharmaceutical.
N-(4-三氟甲基苯基)-5-甲基异噁唑-4-羧酰胺是一种有效的化合物,用于预防和治疗涉及肿瘤坏死因子α的疾病。它被用作药物。